Revolutionary weight management and diabetes medications could prove to be the next frontier in addiction recovery treatment medications.

First patient dosed with ISP-001 shows reduced urinary GAG level, functional improvements surpassing enzyme replacement ...

“ (Weight loss medications) can help, for sure, but exercise and getting enough protein to make sure you aren’t losing muscle ...

Lilly has earmarked $200 million for the upgrade, a company spokesperson confirmed to Fierce Pharma. The new project will ...

DehydraTECH-processed tirzepatide from Zepbound® is being tested in an oral dose format KELOWNA, BC / ACCESSWIRE / October 9, ...

If you're like the vast majority of individual investors, you've never heard of Scholar Rock, apitegromab, or the ...

With the release of the version 2.5 update, there are currently several active Honkai Star Rail redeem codes for players to use. These codes can be exchanged for lucrative rewards like Stellar ...

We recently compiled a list of the 8 Best Momentum Stocks To Invest In Right Now. In this article, we are going to take a ...

The shortage of Eli Lilly’s (LLY) blockbuster diabetes and weight loss drugs is officially over, according to the U.S. Food and Drug Administration (FDA). The FDA updated its drug shortage ...

(Reuters) -The U.S. Food and Drug Administration removed Eli Lilly's blockbuster weight-loss and diabetes drugs from its shortage list late on Wednesday, likely piling pressure on firms selling ...

The investment brings Lilly’s outlay at the sprawling site to $13.5 billion. As sales of Mounjaro and Zepbound have skyrocketed, the company has upped its ante at the LEAP complex. It first ...